Boyle Kevin S. Sr. 4
4 · Alaunos Therapeutics, Inc. · Filed Apr 1, 2022
Insider Transaction Report
Form 4
Boyle Kevin S. Sr.
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-30+2,000,000→ 2,000,000 totalExercise: $0.66Exp: 2032-03-29→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date.